Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations
作者： Markus A. Seeliger , Pratistha Ranjitkar , Corynn Kasap , Yibing Shan , David E. Shaw
DOI: 10.1158/0008-5472.CAN-08-3953
关键词:
摘要: … was screened against three DSA compounds to test the effect of substitutions on ring E (piperazine versus trifluoromethyl). We find that the DSA compounds are … DSA compounds tested …
rcsb.org
aacrjournals.org参考文章(35)
Alan Fersht, Structure and Mechanism in Protein Science : a guide to enzyme catalysis and protein folding W.H. Freeman. ,(2017) , 10.1142/10574
Elena Tamborini, Lorena Bonadiman, Angela Greco, Veronica Albertini, Tiziana Negri, Alessandro Gronchi, Rossella Bertulli, Maurizio Colecchia, Paolo G. Casali, Marco A. Pierotti, Silvana Pilotti, A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. Gastroenterology. ,vol. 127, pp. 294- 299 ,(2004) , 10.1053/J.GASTRO.2004.02.021
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Wenqing Xu, Stephen C. Harrison, Michael J. Eck, Three-dimensional structure of the tyrosine kinase c-Src Nature. ,vol. 385, pp. 595- 602 ,(1997) , 10.1038/385595A0
Airlie J. McCoy, Ralf W. Grosse-Kunstleve, Laurent C. Storoni, Randy J. Read, Likelihood-enhanced fast translation functions. Acta Crystallographica Section D-biological Crystallography. ,vol. 61, pp. 458- 464 ,(2005) , 10.1107/S0907444905001617
Jan Cools, Daniel J. DeAngelo, Jason Gotlib, Elizabeth H. Stover, Robert D. Legare, Jorges Cortes, Jeffrey Kutok, Jennifer Clark, Ilene Galinsky, James D. Griffin, Nicholas C.P. Cross, Ayalew Tefferi, James Malone, Rafeul Alam, Stanley L. Schrier, Janet Schmid, Michal Rose, Peter Vandenberghe, Gregor Verhoef, Marc Boogaerts, Iwona Wlodarska, Hagop Kantarjian, Peter Marynen, Steven E. Coutre, Richard Stone, D. Gary Gilliland, A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome New England Journal of Medicine. ,vol. 348, pp. 1201- 1214 ,(2003) , 10.1056/NEJMOA025217
Neil P. Shah, John M. Nicoll, Bhushan Nagar, Mercedes E. Gorre, Ronald L. Paquette, John Kuriyan, Charles L. Sawyers, Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia Cancer Cell. ,vol. 2, pp. 117- 125 ,(2002) , 10.1016/S1535-6108(02)00096-X
Brian L. Hodous, Stephanie D. Geuns-Meyer, Paul E. Hughes, Brian K. Albrecht, Steve Bellon, James Bready, Sean Caenepeel, Victor J. Cee, Stuart C. Chaffee, Angela Coxon, Maurice Emery, Jenne Fretland, Paul Gallant, Yan Gu, Doug Hoffman, Rebecca E. Johnson, Richard Kendall, Joseph L. Kim, Alexander M. Long, Michael Morrison, Philip R. Olivieri, Vinod F. Patel, Anthony Polverino, Paul Rose, Paul Tempest, Ling Wang, Douglas A. Whittington, Huilin Zhao, Evolution of a Highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor Journal of Medicinal Chemistry. ,vol. 50, pp. 611- 626 ,(2007) , 10.1021/JM061107L
M. R. Burgess, B. J. Skaggs, N. P. Shah, F. Y. Lee, C. L. Sawyers, Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 3395- 3400 ,(2005) , 10.1073/PNAS.0409770102
G. N. Murshudov, A. A. Vagin, E. J. Dodson, Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallographica Section D-biological Crystallography. ,vol. 53, pp. 240- 255 ,(1997) , 10.1107/S0907444996012255